Taiwan is expected to review an application for emergency use authorization (EUA) of the Pfizer-BioNTech second-generation COVID-19 vaccine next week, Central Epidemic Command Center (CECC) head Victor Wang (王必勝) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan minimum wage hike to benefit 2.61 million workers: Labor Ministry
09/24/2026 09:15 PM - Society
New Taipei student critically injured in alleged scissors attack
09/24/2026 08:17 PM - Society
2-year sentences sought for Chinese men who illegally sailed to Taiwan
09/24/2026 08:10 PM - Politics
DPP ousts 18 members over independent local election bids
09/24/2026 07:11 PM - Society
Taiwan raises minimum monthly wage above NT$30,000
09/24/2026 05:58 PM